Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kedrion fibrin glue in cardiovascular surgery (Italy, Phase 3)
2012-002342-21Phase 3Terminated
- Sponsor
- Kedrion Biopharma
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of fibrin sealant in cardiac morbidity, sponsored by Kedrion Biopharma. Started May 2014; status: terminated.
02
Drugs
fibrin sealant
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2012-002342-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002342-21.